KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ralph Lauren (RL) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for Ralph Lauren (RL) over the last 13 years, with Sep 2025 value amounting to $2.8 million.

  • Ralph Lauren's Asset Writedowns and Impairment rose 115.38% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 38.46%. This contributed to the annual value of $9.2 million for FY2025, which is 26.03% up from last year.
  • As of Q3 2025, Ralph Lauren's Asset Writedowns and Impairment stood at $2.8 million, which was up 3.70% from $2.7 million recorded in Q2 2025.
  • Ralph Lauren's 5-year Asset Writedowns and Impairment high stood at $60.3 million for Q1 2021, and its period low was -$1.9 million during Q3 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $1.5 million (2023), whereas its average is $2.9 million.
  • In the last 5 years, Ralph Lauren's Asset Writedowns and Impairment tumbled by 110.22% in 2022 and then spiked by 450.00% in 2023.
  • Ralph Lauren's Asset Writedowns and Impairment (Quarterly) stood at $700,000 in 2021, then plummeted by 71.43% to $200,000 in 2022, then surged by 450.00% to $1.5 million in 2023, then tumbled by 60.00% to $600,000 in 2024, then soared by 115.38% to $2.8 million in 2025.
  • Its Asset Writedowns and Impairment was $2.8 million in Q3 2025, compared to $2.7 million in Q2 2025 and $6.5 million in Q1 2025.